期刊
BIOLOGICAL PSYCHIATRY
卷 60, 期 12, 页码 1309-1313出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2006.03.014
关键词
fasting blood glucose; insulin resistance; schizophrenia; serum free fatty acids
Background Weight gain and type 2 diabetes mellitus (DM) are often linked to antipsychotics treatment. The aim of the study is to investigate serum free fatty acids (FFA) levels in schizophrenic patients who received long-term. antipsychotics treatment, and to explore the associations between serum FFA and fasting blood glucose, and insulin resistance. Methods: 308 inpatients with schizophrenia who met with the criteria of DSM-IV were recruited into this study, and were divided into four groups: control subjects, single obesity, impaired glucose tolerance (IGT) and type 2 DM according to different body mass index, fasting blood glucose level and 2-hour postprandial blood glucose, Serum FFA was measured with colorimetry. Serum insulin and leptin were measured with radioimmunoassay respectively. Results: There was a significant elevation in serum FFA levels in schizophrenic patients who received long-term antipsychotics treatment, especially in single obesity, IGT, and DM groups. The elevated serum FFA was remarkably positive correlated with fasting blood glucose and insulin resistance. Conclusions: The study suggested the elevated serum FFA in schizophrenic patients with long-term antipsychotics treatment affected the blood glucose metabolism, may have played an important role in insulin resistance and type 2 DM, and was also all important trait of metabolic syndromes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据